Using a licensed medicine for a purpose, population, route of administration or other condition of use that falls outside its officially approved indication. A regulator’s approval of a medicine for one use does not extend to other uses that have not been separately assessed. This site does not describe or recommend off-label use; where a regulator has commented on the risks of use outside a licensed indication, that caution is reported as part of the relevant peptide’s regulatory status.
Peptides where this matters
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.